These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Intensive lipid intervention in the post-ENHANCE era. O'Keefe JH; Bybee KA; Lavie CJ Mayo Clin Proc; 2008 Aug; 83(8):867-9. PubMed ID: 18674470 [No Abstract] [Full Text] [Related]
7. More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolemia. Bertolotto A; Bandinelli S; Ruocco L; Lo Faro A; Penno G; Navalesi R Atherosclerosis; 1999 Apr; 143(2):455-7. PubMed ID: 10217377 [No Abstract] [Full Text] [Related]
8. High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia. Wierzbicki AS; Lumb PJ; Semra YK; Crook MA QJM; 1998 Apr; 91(4):291-4. PubMed ID: 9666952 [TBL] [Abstract][Full Text] [Related]
9. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study. Galin ID; Smith DA Am Heart J; 2006 May; 151(5):e1. PubMed ID: 16644302 [No Abstract] [Full Text] [Related]
10. Effect of atorvastatin (80 mg) and simvastatin (40 mg) on plasma fibrinogen levels and on carotid intima media thickness in patients with familial hypercholesterolemia. Trip MD; van Wissen S; Smilde TJ; Hutten BA; Stalenhoef AF; Kastelein JJ Am J Cardiol; 2003 Mar; 91(5):604-6. PubMed ID: 12615272 [No Abstract] [Full Text] [Related]
11. Efficacy of vitamin E compared with either simvastatin or atorvastatin in preventing the progression of atherosclerosis in homozygous familial hypercholesterolemia. Raal FJ; Pilcher GJ; Veller MG; Kotze MJ; Joffe BI Am J Cardiol; 1999 Dec; 84(11):1344-6, A7. PubMed ID: 10614803 [TBL] [Abstract][Full Text] [Related]
12. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Pincus J Am J Cardiol; 1998 Aug; 82(3):406-7. PubMed ID: 9708683 [No Abstract] [Full Text] [Related]
13. Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia. Raal FJ; Pappu AS; Illingworth DR; Pilcher GJ; Marais AD; Firth JC; Kotze MJ; Heinonen TM; Black DM Atherosclerosis; 2000 Jun; 150(2):421-8. PubMed ID: 10856535 [TBL] [Abstract][Full Text] [Related]
14. Reply to Al-Shaer, is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome? (Am Heart J 2005;149:e17.). Milionis HJ; Elisaf MS Am Heart J; 2005 Jul; 150(1):e7. PubMed ID: 16084140 [No Abstract] [Full Text] [Related]
15. Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia. Tomassini JE; Mazzone T; Goldberg RB; Guyton JR; Weinstock RS; Polis A; Jensen E; Tershakovec AM Diabetes Obes Metab; 2009 Sep; 11(9):855-64. PubMed ID: 19508464 [TBL] [Abstract][Full Text] [Related]
16. [The last round about statins: there is the fact that 80 mg simvastatin daily results in high risk of myopathy]. Olsson AG Lakartidningen; 2009 Oct 21-27; 106(43):2783-4; author reply 2784. PubMed ID: 19960911 [No Abstract] [Full Text] [Related]
17. Atorvastatin improves blood rheology in patients with familial hypercholesterolemia (FH) on long-term LDL apheresis treatment. Banyai S; Banyai M; Falger J; Jansen M; Alt E; Derfler K; Koppensteiner R Atherosclerosis; 2001 Dec; 159(2):513-9. PubMed ID: 11730833 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of colestimide coadministered with atorvastatin in japanese patients with heterozygous familial hypercholesterolemia (FH). Kawashiri MA; Higashikata T; Nohara A; Kobayashi J; Inazu A; Koizumi J; Mabuchi H Circ J; 2005 May; 69(5):515-20. PubMed ID: 15849435 [TBL] [Abstract][Full Text] [Related]
19. Statin-induced myositis migrans. Sinzinger H Wien Klin Wochenschr; 2002 Nov; 114(21-22):943-4. PubMed ID: 12528328 [TBL] [Abstract][Full Text] [Related]